Corient Private Wealth LP Sells 26,579 Shares of UnitedHealth Group Incorporated $UNH

Corient Private Wealth LP cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 4.9% in the second quarter, HoldingsChannel reports. The firm owned 520,634 shares of the healthcare conglomerate’s stock after selling 26,579 shares during the period. Corient Private Wealth LP’s holdings in UnitedHealth Group were worth $216,392,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. California State Teachers Retirement System grew its holdings in UnitedHealth Group by 41,749.2% during the 2nd quarter. California State Teachers Retirement System now owns 567,446,754 shares of the healthcare conglomerate’s stock worth $235,847,894,000 after acquiring an additional 566,090,823 shares in the last quarter. Norges Bank bought a new stake in shares of UnitedHealth Group in the 4th quarter valued at about $4,376,167,000. Legal & General Group Plc bought a new position in shares of UnitedHealth Group during the second quarter valued at approximately $2,444,928,000. Jupiter Topco LLC bought a new position in UnitedHealth Group in the second quarter worth approximately $2,019,844,000. Finally, BlackRock Inc. boosted its position in UnitedHealth Group by 4.6% during the 2nd quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock valued at $31,946,594,000 after acquiring an additional 3,395,530 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Key Stories Impacting UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

  • Positive Sentiment: TPG investment could support Optum Health’s turnaround. UnitedHealth is selling a partial stake in certain Florida WellMed primary-care operations to TPG while retaining an interest. The deal brings local investment and strategic support that management expects could accelerate growth, improve clinic performance and strengthen profitability. UnitedHealth Reshapes Florida WellMed Operations With TPG Deal
  • Positive Sentiment: Management continues to point to areas of operational progress. Commentary at the Wells Fargo healthcare conference reportedly indicated stronger Medicare Advantage performance and a steadier Medicaid outlook. Analysts remain constructive in some cases, with the median recent price target above the current trading range. UnitedHealth Wells Fargo Conference Transcript
  • Positive Sentiment: Reduced prior-authorization requirements may improve efficiency. UnitedHealthcare plans to remove authorization requirements for additional services beginning October 1, targeting 30% of healthcare services by the end of 2026. The initiative could lower administrative costs and improve relationships with patients and providers, although its financial benefit remains uncertain. UnitedHealth is Removing More Prior Authorizations
  • Neutral Sentiment: UnitedHealth is investing heavily in artificial intelligence. Nearly $1.5 billion is being directed toward AI and Optum Insight software, with the goal of increasing efficiency and creating new growth opportunities. The strategy could support longer-term expansion, but it also requires substantial investment before results are visible. UnitedHealth’s AI Strategy
  • Negative Sentiment: The WellMed transaction is raising concerns about Optum Health. Investors may view bringing in TPG as evidence that the Florida clinic business needs outside capital or operational assistance. The clinics were among the operations associated with UnitedHealth’s recent profit setbacks, making the deal a reminder that the Optum turnaround remains incomplete. UnitedHealth Sells WellMed to TPG
  • Negative Sentiment: Medical-cost and margin concerns continue to weigh on managed-care stocks. Comments from CVS Health about persistently high medical-cost trends hurt sentiment across the sector. UnitedHealth also faces pressure in commercial insurance, while its valuation remains elevated relative to some peers despite slower revenue growth. CVS Still Sees High-Trend Cost Growth

UnitedHealth Group Stock Performance

NYSE UNH opened at $387.69 on Friday. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The stock has a market capitalization of $347.98 billion, a price-to-earnings ratio of 24.95, a PEG ratio of 1.48 and a beta of 0.61. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66. The stock has a 50-day moving average of $409.50 and a 200 day moving average of $367.63.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The firm’s revenue for the quarter was up .4% compared to the same quarter last year. During the same quarter last year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 19.82 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be given a dividend of $2.32 per share. The ex-dividend date is Monday, September 14th. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. UnitedHealth Group’s payout ratio is presently 59.72%.

Analysts Set New Price Targets

Several research firms have commented on UNH. Zacks Research raised shares of UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th. Wall Street Zen raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Saturday, August 8th. HC Wainwright set a $492.00 price target on UnitedHealth Group in a research note on Wednesday, May 27th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a research note on Wednesday, September 2nd. Finally, TD Cowen raised their price target on shares of UnitedHealth Group from $337.00 to $430.00 and gave the stock a “hold” rating in a research report on Tuesday, July 14th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating and six have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $456.56.

Check Out Our Latest Analysis on UnitedHealth Group

Insider Activity

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.19% of the stock is owned by company insiders.

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated is a diversified health care and well-being company headquartered in Minnetonka, Minnesota. Its operations are organized primarily through two businesses: UnitedHealthcare, which provides health benefit plans and services, and Optum, which delivers health care services, technology, pharmacy care and data-driven solutions.

UnitedHealthcare serves individuals, employers, government programs and other organizations through products that include employer-sponsored health plans, individual and family coverage, Medicare and Medicaid plans, dental and vision benefits, and related administrative services.

See Also

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.